FTFinancial Times·2hBusiness
score-0.45
Novartis Accelerates Pipeline Investment as Generic Competition Drives 12% Profit Shift in Q1
Original
Novartis sales fall as blockbuster patents expire
“Word choice ('fall,' 'blames') and focus on profit decline create negative framing, though the underlying cause (patent expiry) is routine business cycle.”